The Prescription Access Litigation (PAL) Project works to make prescription drug prices more affordable for everyone by going straight to the source of the increased costs – the drug companies. An affiliate of Community Catalyst, PAL accomplishes its goals through class action litigation and public education. PAL is a national coalition of more than 125 consumer, senior, heath care, labor, legal services, and human services organization in 36 states and the District of Columbia. PAL publishes a blog that reports on PAL cases and offers PAL's commentary on drug industry news.
PAL and its members have been involved in 28 class action lawsuits, challenging drug industry tactics that illegally raise the price of prescription drugs. To date, seven of these cases have settled for a combined total of $438 million in reimbursements for consumers who were illegally overcharged.
PAL’s cases challenge a variety of illegal practices like illegal marketing and pricing that make it harder for low-income families, seniors, and others to afford the medications they need. Whether we take prescription drugs or not, the deceptive promotion of prescription drugs distorts the practice of medicine and drives up the cost of health care for all. PAL has already changed – and continues to change – industry behavior, increasing consumer access to vital drugs and lowering costs.
In 2007, PAL became a separate limited liability corporation that reports directly to the Community Catalyst board of directors.